Dodgers' Jose D. Hernandez Suspended for 2025 ACL Season

Los Angeles Dodgers shortstop Jose D. Hernandez has been suspended for the upcoming Arizona Complex League (ACL) season following a positive test for boldenone and nandrolone, under baseball's minor league drug program.

Hernandez's Performance and Background
Hernandez, 21, had an impressive season with the ACL Dodgers, hitting .302 with four home runs and 21 RBIs in 26 games. The Venezuelan native joined the Dodgers organization in 2019, signing a contract that included a $10,000 signing bonus.

Context of the Suspension
This year, a total of 20 players have been suspended for positive drug tests, with nine suspensions under the minor league program and another nine under the program for minor league players based outside the United States and Canada. Two players have also been suspended under the major league drug program.

Notable Suspensions:

• Noelvi Marté, a top prospect for the Cincinnati Reds, missed the first 80 games of the season following a positive test for boldenone.
  
• Toronto Blue Jays infielder Orelvis Martínez was suspended for 80 games on June 23 after testing positive for the performance-enhancing drug clomiphene, just two days after his major league debut.
  

Implications for Hernandez
​Hernandez's suspension is a significant setback for both the player and the Dodgers organization. As he looks forward to next season, the focus will likely be on maintaining his performance and avoiding any further violations.